科翔股份(300903) - 2021 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2021 was CNY 447,117,612.53, representing a 59.26% increase compared to CNY 280,751,976.30 in the same period last year[8]. - Net profit attributable to shareholders was CNY 14,246,304.89, up 13.42% from CNY 12,560,119.09 year-over-year[8]. - The company achieved operating revenue of CNY 447.12 million, a year-on-year increase of 59.26% driven by order growth[18]. - Net profit attributable to shareholders reached CNY 14.25 million, reflecting a 13.42% increase compared to the same period last year[18]. - Total operating revenue for Q1 2021 reached ¥447,117,612.53, a significant increase of 59.4% compared to ¥280,751,976.30 in the same period last year[46]. - Net profit for Q1 2021 was ¥14,246,304.89, representing a year-on-year increase of 13.5% from ¥12,560,119.09[48]. Cash Flow - The net cash flow from operating activities surged by 1,101.96%, reaching CNY 36,136,668.93 compared to CNY 3,006,489.86 in the previous year[8]. - Cash inflow from operating activities totaled CNY 401.18 million, up 64.75% primarily due to increased accounts receivable recovery[17]. - Operating cash inflow for the first quarter was CNY 401,184,730.77, an increase of 64.5% from CNY 243,507,316.92 in the previous year[56]. - The net cash flow from operating activities was CNY 36,136,668.93, significantly up from CNY 3,006,489.86 in the same quarter of the previous year[56]. - The company's cash flow from investment activities included CNY 300,003,221.92 received from other investment-related activities[59]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,360,342,171.01, a 4.81% increase from CNY 2,251,971,831.23 at the end of the previous year[8]. - Total liabilities increased to CNY 1,199,080,293.28 from CNY 1,104,956,258.39, an increase of approximately 8.5%[40]. - Current assets decreased to CNY 1,735,797,930.83 from CNY 1,797,060,135.33, a decline of about 3.5%[38]. - Inventory increased significantly to CNY 211,316,213.63, up from CNY 165,215,440.78, marking a rise of approximately 27.9%[38]. - The total equity attributable to shareholders increased to CNY 1,161,261,877.73 from CNY 1,147,015,572.84, reflecting a growth of about 1.2%[41]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 25,792[12]. - The top shareholder, Zheng Xiaoyong, holds 19.83% of the shares, amounting to 34,169,684 shares[12]. Research and Development - Research and development expenses rose to CNY 21.35 million, a 77.33% increase due to the expansion of R&D projects[18]. - Research and development expenses increased to ¥21,348,049.99, a rise of 77.5% compared to ¥12,038,924.28 in Q1 2020[47]. Dividends and Fundraising - The company approved a cash dividend of RMB 0.65 per share, totaling RMB 11,201,950.11, based on a total share capital of 172,337,694 shares[26]. - The total amount of raised funds is RMB 50,165.43 million, with RMB 6,200 million invested in the current quarter, and a cumulative investment of RMB 8,000 million[29]. - The fundraising project is expected to commence production in the second half of the year, contributing to future revenue growth[18]. Risk Management - The company is preparing for potential risks from macroeconomic fluctuations and intensified market competition[21][22]. - The company has implemented measures to manage inventory and optimize procurement orders to mitigate risks from raw material price fluctuations[25]. Other Financial Metrics - The company reported a weighted average return on equity of 1.23%, down from 2.13% in the previous year[8]. - The total comprehensive income for the first quarter of 2021 was CNY 8,314,110.06, compared to CNY 1,958,046.54 in the same period last year[53]. - The financial expenses for the quarter were ¥1,096,268.90, compared to a negative expense of -¥600,036.47 in the previous year[47].